Integrated Multi‐Cohort Analysis of the Parkinson's Disease Gut Metagenome
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: The gut microbiome is altered in several neurologic disorders, including Parkinson's disease (PD). Objectives: The aim is to profile the fecal gut metagenome in PD for alterations in microbial composition, taxon abundance, metabolic pathways, and microbial gene products, and their relationship with disease progression. Methods: Shotgun metagenomic sequencing was conducted on 244 stool donors from two independent cohorts in the United States, including individuals with PD (n = 48, n = 47, respectively), environmental household controls (HC, n = 29, n = 30), and community population controls (PC, n = 41, n = 49). Microbial features consistently altered in PD compared to HC and PC subjects were identified. Data were cross‐referenced to public metagenomic data sets from two previous studies in Germany and China to determine generalizable microbiome features. Results: We find several significantly altered taxa between PD and controls within the two cohorts sequenced in this study. Analysis across global cohorts returns consistent changes only in Intestinimonas butyriciproducens . Pathway enrichment analysis reveals disruptions in microbial carbohydrate and lipid metabolism and increased amino acid and nucleotide metabolism in PD. Global gene‐level signatures indicate an increased response to oxidative stress, decreased cellular growth and microbial motility, and disrupted intercommunity signaling. Conclusions: A metagenomic meta‐analysis of PD shows consistent and novel alterations in functional metabolic potential and microbial gene abundance across four independent studies from three continents. These data reveal that stereotypic changes in the functional potential of the gut microbiome are a consistent feature of PD, highlighting potential diagnostic and therapeutic avenues for future research. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Self-citationMicrobiome Datasets Are Compositional: And This Is Not Optional
Gloor, G. B., Macklaim, J. M., Pawlowsky-Glahn, V., & Egozcue, J. J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02224 · Cited by 3,044
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., & Kasper, D. L. (2005) · Cell · doi:10.1016/j.cell.2005.05.007 · Cited by 2,910 · cited 1×
“The gut microbiome represents hundreds of species of bacteria, fungi, archaea, and viruses that have been linked to the regulation of the immune, metabolic, and nervous systems.(13-17) Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comor…”
BackgroundSelf-citationLife between Clocks: Daily Temporal Patterns of Human Chronotypes
Roenneberg, T., Wirz-Justice, A., & Merrow, M. (2003) · Journal of Biological Rhythms · doi:10.1177/0748730402239679 · Cited by 2,662
Multivariable association discovery in population-scale meta-omics studies
Mallick, H., Rahnavard, A., McIver, L. J., Ma, S., Zhang, Y., Nguyen, L. H., Tickle, T. L., Weingart, G., Ren, B., Schwager, E. H., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009442 · Cited by 2,596 · cited 1×
“To determine feature associations with PD status, we utilized Multivariable Association with Linear Models (MaAsLin2).(43) The detailed description of all statistical analyses can be found in Supplementary Methods.”
MethodBeghini, F., McIver, L. J., Blanco-Míguez, A., Dubois, L., Asnicar, F., Maharjan, S., Mailyan, A., Manghi, P., Scholz, M., Thomas, A. M., et al. (2021) · eLife · doi:10.7554/elife.65088 · Cited by 2,303
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053 · cited 1×
“Curiously, non-motor symptoms, including hyposmia, depression, sleep disruption, and gastrointestinal (GI) distress such as constipation, may appear years prior to PD diagnosis.(9-12) The gut microbiome represents hundreds of species of bacteria, fungi, archaea, and viruses that have been linked to the regulation of t…”
BackgroundInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
Roenneberg, T., Allebrandt, K. V., Merrow, M., & Vetter, C. (2012) · Current Biology · doi:10.1016/j.cub.2012.03.038 · Cited by 1,407
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281 · cited 10×
“Pathway associations shared in both control group comparisons include 55 enrichments and 12 depletions in PD.”
BackgroundSelf-citationUnger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874 · cited 3×
“2).(20,23,25,33) These data show robust gut dysbiosis at the level of microbial abundance, but not taxonomic representation, which is more uniform across study groups.”
BackgroundSelf-citationInterplay between the human gut microbiome and host metabolism
Visconti, A., Le Roy, C. I., Rosa, F., Rossi, N., Martin, T. C., Mohney, R. P., Li, W., de Rinaldis, E., Bell, J. T., Venter, J. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12476-z · Cited by 782 · cited 1×
“The gut microbiome represents hundreds of species of bacteria, fungi, archaea, and viruses that have been linked to the regulation of the immune, metabolic, and nervous systems.(13-17) Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comor…”
BackgroundBedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Colonic inflammation in Parkinson's disease
Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., Coron, E., Bruley des Varannes, S., Naveilhan, P., Nguyen, J.-M., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.09.007 · Cited by 627 · cited 7×
“Pathway associations shared in both control group comparisons include 55 enrichments and 12 depletions in PD.”
BackgroundInfluentialQin, Y., Havulinna, A. S., Liu, Y., Jousilahti, P., Ritchie, S. C., Tokolyi, A., Sanders, J. G., Valsta, L., Brożyńska, M., Zhu, Q., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-00991-z · Cited by 586
Self-citationThe maternal microbiome modulates fetal neurodevelopment in mice
Vuong, H. E., Pronovost, G. N., Williams, D. W., Coley, E. J. L., Siegler, E. L., Qiu, A., Kazantsev, M., Wilson, C. J., Rendon, T., & Hsiao, E. Y. (2020) · Nature · doi:10.1038/s41586-020-2745-3 · Cited by 564 · cited 1×
“The gut microbiome represents hundreds of species of bacteria, fungi, archaea, and viruses that have been linked to the regulation of the immune, metabolic, and nervous systems.(13-17) Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comor…”
BackgroundHeintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554 · cited 1×
“Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comorbidity of prodromal constipation.(19-30) Previous studies analyzing the fecal microbiome in PD via 16S amplicon profiling have found changes in multiple taxa compared to healthy control…”
BackgroundDietary fructose feeds hepatic lipogenesis via microbiota-derived acetate
Zhao, S., Jang, C., Liu, J., Uehara, K., Gilbert, M., Izzo, L., Zeng, X., Trefely, S., Fernandez, S., Carrer, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2101-7 · Cited by 553 · cited 1×
“Microbial metabolites influence the function of the metabolic, immune, and nervous systems in animals and humans.(46-48) We inferred the microbial metabolic potential of the PD microbiome through MetaCyc pathway abundance.”
BackgroundIntestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523 · cited 1×
“Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comorbidity of prodromal constipation.(19-30) Previous studies analyzing the fecal microbiome in PD via 16S amplicon profiling have found changes in multiple taxa compared to healthy control…”
BackgroundChronotypes in the US–influence of age and sex
Fischer, D., Lombardi, D. A., Marucci-Wellman, H., & Roenneberg, T. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178782 · Cited by 502
Intestinal infection triggers Parkinson's disease-like symptoms in Pink1(-/-) mice
Matheoud, D., Cannon, T., Voisin, A., Penttinen, A.-M., Ramet, L., Fahmy, A. M., Ducrot, C., Laplante, A., Bourque, M.-J., Zhu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1405-y · Cited by 496 · cited 1×
“Differential abundance of individual taxa in disease states can inform potential microbiome influences on host physiology.(45) To broadly assess differences between PC and HC samples, we conducted differential abundance testing at the species and KEGG orthology levels (Fig.”
MethodA gut-derived metabolite alters brain activity and anxiety behaviour in mice
Needham, B. D., Funabashi, M., Adame, M. D., Wang, Z., Boktor, J. C., Haney, J., Wu, W.-L., Rabut, C., Ladinsky, M. S., Hwang, S.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-04396-8 · Cited by 489 · cited 1×
“Microbial metabolites influence the function of the metabolic, immune, and nervous systems in animals and humans.(46-48) We inferred the microbial metabolic potential of the PD microbiome through MetaCyc pathway abundance.”
BackgroundSelf-citationAnalysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487 · cited 1×
“Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comorbidity of prodromal constipation.(19-30) Previous studies analyzing the fecal microbiome in PD via 16S amplicon profiling have found changes in multiple taxa compared to healthy control…”
BackgroundA gut bacterial amyloid promotes α-synuclein aggregation and motor impairment in mice
Sampson, T. R., Challis, C., Jain, N., Moiseyenko, A., Ladinsky, M. S., Shastri, G. G., Thron, T., Needham, B. D., Horvath, I., Debelius, J. W., et al. (2020) · eLife · doi:10.7554/elife.53111 · Cited by 439
Self-citationLi, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Wang, D. D., Nguyen, L. H., Li, Y., Yan, Y., Ma, W., Rinott, E., Ivey, K. L., Shai, I., Willett, W. C., Hu, F. B., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01223-3 · Cited by 386
Immune regulation by microbiome metabolites
Kim, C. H. (2018) · Immunology · doi:10.1111/imm.12930 · Cited by 375
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Aho, V. T. E., Pereira, P. A. B., Voutilainen, S., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.05.064 · Cited by 361 · cited 1×
“Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comorbidity of prodromal constipation.(19-30) Previous studies analyzing the fecal microbiome in PD via 16S amplicon profiling have found changes in multiple taxa compared to healthy control…”
BackgroundKantermann, T., Sung, H., & Burgess, H. J. (2015) · Journal of Biological Rhythms · doi:10.1177/0748730415597520 · Cited by 323
Gut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318
Schwimmer, J. B., Johnson, J. S., Angeles, J. E., Behling, C., Belt, P. H., Borecki, I., Bross, C., Durelle, J., Goyal, N. P., Hamilton, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.028 · Cited by 298
Gut microbiota in patients with Parkinson's disease in southern China
Lin, A., Zheng, W., He, Y., Tang, W., Wei, X., He, R., Huang, W., Su, Y., Huang, Y., Zhou, H., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.05.007 · Cited by 253 · cited 1×
“Dysbiosis, defined as a comparative alteration in microbiome composition,(18) has been implicated in PD and may be linked to the comorbidity of prodromal constipation.(19-30) Previous studies analyzing the fecal microbiome in PD via 16S amplicon profiling have found changes in multiple taxa compared to healthy control…”
BackgroundWallen, Z. D., Appah, M., Dean, M. N., Sesler, C. L., Factor, S. A., Molho, E., Zabetian, C. P., Standaert, D. G., & Payami, H. (2020) · npj Parkinson s Disease · doi:10.1038/s41531-020-0112-6 · Cited by 252
Rosario, D., Bidkhori, G., Lee, S., Bedarf, J., Hildebrand, F., Le Chatelier, E., Uhlen, M., Ehrlich, S. D., Proctor, G., Wüllner, U., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108807 · Cited by 167 · cited 1×
“Studies examining the gut metagenome in PD have identified PD-related alterations in microbial metabolic pathways, including homocysteine, folate, and sulfur metabolism.(20,36-38) Using integrated modeling of metagenomic and metabolomic data, these studies have identified differentially abundant plasma metabolites in…”
BackgroundHertel, J., Harms, A. C., Heinken, A., Baldini, F., Thinnes, C. C., Glaab, E., Vasco, D. A., Pietzner, M., Stewart, I. D., Wareham, N. J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.035 · Cited by 162
Gut Metagenomics-Derived Genes as Potential Biomarkers of Parkinson’s Disease
Qian, Y., Yang, X., Xu, S., Huang, P., Li, B., Du, J., He, Y., Su, B., Xu, L.-M., Wang, L., et al. (2020) · Brain · doi:10.1093/brain/awaa201 · Cited by 139
Li, F., Wang, P., Chen, Z., Sui, X., Xie, X., & Zhang, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134297 · Cited by 97 · cited 2×
“Notable depletions at the genus level in PD are the commensal bacteria Roseburia, Lachnospiraceae, Blautia, Prevotella, Faecalibacterium, and Eubacterium, whereas Lactobacillus, Bifidobacterium, Akkermansia, and Alistipes are typically enriched in PD compared to healthy controls.(23,25,27,33-36) Studies examining the…”
Background
Cited by
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes
Palacios, N., Wilkinson, J., Bjornevik, K., Schwarzschild, M. A., McIver, L., Ascherio, A., & Huttenhower, C. (2023) · Annals of Neurology · doi:10.1002/ana.26719 · Cited by 59
The gut–brain axis in early Parkinson’s disease: from prodrome to prevention
Oliver, P. J., Civitelli, L., & Hu, M. T. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13138-5 · Cited by 42
“One solution is for future studies to use shotgun sequencing of entire bacterial genomes, as some recent studies have moved towards [101], although such measures will be resource and time intensive.”
Alpha synuclein overexpression can drive microbiome dysbiosis in mice
Sampson, T. R., Wallen, Z. D., Won, W.-J., Standaert, D. G., Payami, H., & Harms, A. S. (2025) · Scientific Reports · doi:10.1038/s41598-024-82139-7 · Cited by 11
Metadata
- Authors
- Boktor, J. C., Sharon, G., Verhagen Metman, L. A., Hall, D. A., Engen, P. A., Zreloff, Z., Hakim, D. J., Bostick, J. W., Ousey, J., Lange, D., Humphrey, G., Ackermann, G., Carlin, M., Knight, R., Keshavarzian, A., & Mazmanian, S. K.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2023-01-24
- Volume
- 38
- Issue
- 3
- Pages
- 399-409
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W4317830385
- Cited by
- 68
- References
- 39
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.